CA3216972A1 - Manufacturing of dimeric contrast agents - Google Patents
Manufacturing of dimeric contrast agents Download PDFInfo
- Publication number
- CA3216972A1 CA3216972A1 CA3216972A CA3216972A CA3216972A1 CA 3216972 A1 CA3216972 A1 CA 3216972A1 CA 3216972 A CA3216972 A CA 3216972A CA 3216972 A CA3216972 A CA 3216972A CA 3216972 A1 CA3216972 A1 CA 3216972A1
- Authority
- CA
- Canada
- Prior art keywords
- solution
- formula
- compound
- water
- gadolinium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/122—Macromolecular compounds dimers of complexes or complex-forming compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21187883.0 | 2021-07-27 | ||
| EP21187883 | 2021-07-27 | ||
| PCT/EP2022/070901 WO2023006721A1 (en) | 2021-07-27 | 2022-07-26 | Manufacturing of dimeric contrast agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3216972A1 true CA3216972A1 (en) | 2023-02-02 |
Family
ID=77367218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3216972A Pending CA3216972A1 (en) | 2021-07-27 | 2022-07-26 | Manufacturing of dimeric contrast agents |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12290576B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4377323B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7774081B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240034693A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117412980A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022317221A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022921A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216972A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3041651T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308888A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014582A (cg-RX-API-DMAC7.html) |
| PL (1) | PL4377323T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023006721A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2991736T3 (es) * | 2020-07-27 | 2024-12-04 | Bracco Imaging Spa | Fabricación de agentes de contraste diméricos |
| AU2022318032A1 (en) * | 2021-07-27 | 2023-12-21 | Bracco Imaging Spa | Process for the manufacturing of a gadolinium complex solution |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4009119A1 (de) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| DE4035760A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| IT1291624B1 (it) * | 1997-04-18 | 1999-01-11 | Bracco Spa | Chelati complessi di metalli paramagnetici a bassa tossicita' |
| DE19849465A1 (de) | 1998-10-21 | 2000-04-27 | Schering Ag | Dimere Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel |
| IT1304501B1 (it) * | 1998-12-23 | 2001-03-19 | Bracco Spa | Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza |
| PL3753929T3 (pl) | 2015-12-10 | 2023-03-13 | Bracco Imaging Spa | Dimeryczne środki kontrastowe |
| IL293806B1 (en) * | 2019-12-13 | 2026-05-01 | Bracco Imaging Spa | Production of protected DO3A salts |
-
2022
- 2022-07-26 MX MX2023014582A patent/MX2023014582A/es unknown
- 2022-07-26 WO PCT/EP2022/070901 patent/WO2023006721A1/en not_active Ceased
- 2022-07-26 AU AU2022317221A patent/AU2022317221A1/en active Pending
- 2022-07-26 BR BR112023022921A patent/BR112023022921A2/pt unknown
- 2022-07-26 IL IL308888A patent/IL308888A/en unknown
- 2022-07-26 US US18/565,770 patent/US12290576B2/en active Active
- 2022-07-26 EP EP22754878.1A patent/EP4377323B1/en active Active
- 2022-07-26 CN CN202280039128.1A patent/CN117412980A/zh active Pending
- 2022-07-26 KR KR1020237042178A patent/KR20240034693A/ko active Pending
- 2022-07-26 JP JP2023577348A patent/JP7774081B2/ja active Active
- 2022-07-26 ES ES22754878T patent/ES3041651T3/es active Active
- 2022-07-26 PL PL22754878.1T patent/PL4377323T3/pl unknown
- 2022-07-26 CA CA3216972A patent/CA3216972A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4377323A1 (en) | 2024-06-05 |
| CN117412980A (zh) | 2024-01-16 |
| AU2022317221A1 (en) | 2023-11-16 |
| IL308888A (en) | 2024-01-01 |
| PL4377323T3 (pl) | 2025-12-01 |
| EP4377323C0 (en) | 2025-07-02 |
| KR20240034693A (ko) | 2024-03-14 |
| ES3041651T3 (en) | 2025-11-13 |
| US12290576B2 (en) | 2025-05-06 |
| MX2023014582A (es) | 2023-12-13 |
| WO2023006721A1 (en) | 2023-02-02 |
| BR112023022921A2 (pt) | 2024-02-27 |
| US20240269330A1 (en) | 2024-08-15 |
| JP7774081B2 (ja) | 2025-11-20 |
| JP2024527691A (ja) | 2024-07-26 |
| EP4377323B1 (en) | 2025-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12290576B2 (en) | Manufacturing of dimeric contrast agents | |
| CN102399199B (zh) | 一种磁共振成像造影剂的制备方法 | |
| CN116419920B (zh) | 二聚体造影剂的制造 | |
| EP4448499B1 (en) | Manufacturing of dimeric contrast agent | |
| CN103068790A (zh) | 用于制备结晶的3,6,9-三氮杂-3,6,9-三(羧甲基)-4-(4-乙氧基苄基)十一烷二酸的方法以及用于制备普美显*（Primovist*）的用途 | |
| MX2007013113A (es) | Sintesis de derivados de ciclen. | |
| CA3217274A1 (en) | Process for the manufacturing of a gadolinium complex solution | |
| HK40088886A (en) | Manufacturing of dimeric contrast agents | |
| US20250051292A1 (en) | Process for manufacturing a mixture comprising a dimeric macrocycle intermediate of a gadolinium complex | |
| HK1184437A (en) | Process for preparing crystalline 3,6,9-triaza-3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist® |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240719 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240719 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250718 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250718 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260707 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260707 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260717 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260717 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260730 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260730 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260731 |